Camille L Bedrosian Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 1 month, 1 week ago
Camille L Bedrosian has an estimated net worth of at least $10.1 million*, as of Sept. 2, 2026. They own 280,145 shares of AMLX stock. They have sold 54,614 shares of AMLX stock since 2021, for an estimated $204,067.
Camille L Bedrosian $AMLX SEC Form 4 Insider Trading
Camille L Bedrosian has filed a total of 6 insider trades in $AMLX since 2021. Their most recent trade was a sale of 7,947 shares, made on Sep 10, 2026. Their largest trade was a sale of 12,425 shares, made on Mar 31, 2025. We estimate that they now own 280,145 shares of $AMLX, worth an estimated $9.9 million.
Insider Trading at $AMLX
There have been a total of 137 insider trades reported at $AMLX since 2021, with 2.8 million shares purchased and 3.4 million shares sold. The most active insider traders in $AMLX stock have been Gina Mazzariello, Joshua B Cohen, and Justin B. Klee. The most recent trade was a sale of 30,000 shares reported by GEORGE M JR MILNE (None), made on Oct 05, 2026.
History of Insider Stock Trades by Camille L Bedrosian
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
AMLX
|
Sale | 7,947 | Sep 10, 2026 | Sept. 14, 2026, 4:03 p.m. |
|
AMLX
|
Sale | 2,081 | Sep 10, 2026 | Sept. 14, 2026, 4:03 p.m. |
|
AMLX
|
Sale | 6,580 | Dec 01, 2025 | Dec. 3, 2025, 5:39 p.m. |
|
AMLX
|
Sale | 12,425 | Mar 31, 2025 | April 2, 2025, 5:14 p.m. |
|
AMLX
|
Sale | 5,421 | Dec 02, 2024 | Dec. 3, 2024, 6:21 p.m. |
|
AMLX
|
Sale | 11,442 | Sep 30, 2024 | Oct. 2, 2024, 6:50 p.m. |
RARE
|
Sale | 3,881 | Mar 01, 2023 | March 3, 2023, 9 p.m. |
|
RARE
|
Sale | 2,821 | Mar 01, 2022 | March 2, 2022, 8 p.m. |
|
RARE
|
Sale | 1,657 | Jan 30, 2022 | Feb. 1, 2022, 2:39 p.m. |
|
RARE
|
Sale | 359 | Oct 14, 2021 | Oct. 17, 2021, 8 p.m. |
$AMLX Executives and Stock Owners with Insider Trades
-
Gina Mazzariello, Chief Legal Officer
-
Joshua B Cohen, Co-Chief Executive Officer
-
Justin B. Klee, Co-Chief Executive Officer
-
James M Frates, Chief Financial Officer
-
Patrick D Yeramian, Chief Medical Officer
-
Camille L Bedrosian, Chief Medical Officer
-
Margaret Olinger, Chief Commercial Officer
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.